Home LiteratureArticle Details
PMID: 21954284 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.

Journal of leukocyte biology ·Vol. 91 ·No. 1 ·2012-01-00 ·Pages 167-81

Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI

Abstract

MDSCs are a group of cells with potent immune-suppressive activity. These cells accumulate in many pathologic conditions and play a major role in the regulation of immune responses. The nature of MDSC remains highly debatable. In cancer, most MDSCs are represented by cells with granulocytic phenotype and morphology, G-MDSC. The relationship between G-MDSCs and Neu remains unclear. In this study, we have found that G-MDSCs, from tumor-bearing, and Neu, from tumor-free, mice share a common morphology and phenotype. However, in contrast to Neu, a substantial proportion of G-MDSCs expressed M-CSFR and a CD244 molecule. Neu had significantly higher phagocytic activity, expression of lysosomal proteins, and TNF-α than corresponding G-MDSCs, which had significantly higher activity of arginase, MPO, and ROS. In contrast to G-MDSC, neither rested nor mobilized Neu suppressed T cells. G-MDSC survived 2 days in culture in the presence of GM-CSF and within 24 h, became phenotypic and functionally similar to Neu. Tumor-associated G-MDSC shared most characteristics of splenic G-MDSC, rather then Neu. These data suggest that in cancer, despite morphological and phenotypic similarities, G-MDSCs are functionally distinct from Neu and are comprised of pathologically activated precursors of Neu.

MeSH Terms
Animals Cell Line, Tumor Colonic Neoplasms/immunology,pathology Disease Models, Animal Female Granulocytes/cytology,immunology Immunophenotyping/methods Melanoma/immunology,pathology Mice Mice, Inbred C57BL Myeloid Cells/cytology,immunology Phagocytosis/immunology Skin Neoplasms/immunology,pathology Thymoma/immunology,pathology Thymus Neoplasms/immunology,pathology
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Youn Je-In
H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USA.
Collazo Michelle
Shalova Irina N
Biswas Subhra K
Gabrilovich Dmitry I
References (27)
27 references, click to expand
  1. Amplified RNA synthesized from limited quantities of heterogeneous cDNA.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1663-7 PMID: 1689846
  2. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
    Stem Cells. 2010 Mar 31;28(3):620-32 PMID: 20073041
  3. Determination of arginase activity in macrophages: a micromethod.
    J Immunol Methods. 1994 Sep 14;174(1-2):231-5 PMID: 8083527
  4. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    J Immunol. 2008 Oct 1;181(7):4666-75 PMID: 18802069
  5. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.
    Nat Biotechnol. 2007 Aug;25(8):911-20 PMID: 17664940
  6. Fine-tuning of immune responses by SLAM-related receptors.
    J Leukoc Biol. 2006 Mar;79(3):417-24 PMID: 16365151
  7. An integrated view of humoral innate immunity: pentraxins as a paradigm.
    Annu Rev Immunol. 2010;28:157-83 PMID: 19968561
  8. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
    Clin Cancer Res. 2009 Mar 15;15(6):2148-57 PMID: 19276286
  9. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.
    J Exp Med. 2010 Oct 25;207(11):2439-53 PMID: 20876310
  10. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
    J Immunol. 2009 May 1;182(9):5693-701 PMID: 19380816
  11. Myeloid-derived suppressor cell heterogeneity and subset definition.
    Curr Opin Immunol. 2010 Apr;22(2):238-44 PMID: 20171075
  12. Myeloid-derived suppressor cells: linking inflammation and cancer.
    J Immunol. 2009 Apr 15;182(8):4499-506 PMID: 19342621
  13. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes.
    Physiol Genomics. 2000 Apr 27;2(3):143-7 PMID: 11015593
  14. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
    Cancer Res. 2009 Feb 15;69(4):1553-60 PMID: 19201693
  15. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
    J Immunol. 2004 Jan 15;172(2):989-99 PMID: 14707072
  16. Analysis of high density expression microarrays with signed-rank call algorithms.
    Bioinformatics. 2002 Dec;18(12):1593-9 PMID: 12490443
  17. Chemokines: novel targets for breast cancer metastasis.
    Cancer Metastasis Rev. 2007 Dec;26(3-4):401-20 PMID: 17717637
  18. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.
    Blood. 2008 Apr 15;111(8):4233-44 PMID: 18272812
  19. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
    Cancer Cell. 2008 Jan;13(1):23-35 PMID: 18167337
  20. Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
    J Immunol. 2008 Oct 15;181(8):5791-802 PMID: 18832739
  21. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.
    J Exp Med. 2008 Sep 29;205(10):2235-49 PMID: 18809714
  22. TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung.
    Mucosal Immunol. 2010 Nov;3(6):578-93 PMID: 20664577
  23. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
    Cancer Res. 2001 Jun 15;61(12):4756-60 PMID: 11406548
  24. Myeloid-derived suppressor cells as regulators of the immune system.
    Nat Rev Immunol. 2009 Mar;9(3):162-74 PMID: 19197294
  25. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.
    Cancer Cell. 2004 Oct;6(4):409-21 PMID: 15488763
  26. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).
    Blood. 2006 Mar 1;107(5):2112-22 PMID: 16269622
  27. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
    Cancer Cell. 2009 Sep 8;16(3):183-94 PMID: 19732719
Article Info
Journal
Journal of leukocyte biology
Abbr.
J Leukoc Biol
ISSN
1938-3673
Published
2012-01-00
Epub
2011-00-27
Pages
167-81
Language
English
Region
United States
NLM ID
8405628
PMCID
PMC3250305
Subset
IM
Grants
ODCDC CDC HHS · CD84488 · United States
NCI NIH HHS · R01 CA084488 · United States
NCI NIH HHS · R01 CA084488-14 · United States
NCI NIH HHS · P30 CA076292 · United States
NCI NIH HHS · R01 CA100062-09 · United States
NCI NIH HHS · CA100062 · United States
NCI NIH HHS · R01 CA100062 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]